Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRG-001 in Acute Respiratory Distress Syndrome
NCT06308926Phase 2Not yet recruiting
- Sponsor
- MedRegen LLC
- Start
- Dec 2024
- Primary completion
- Feb 2026
- Modality
- RNA-Targeting Small Molecules
01
Overview
A Phase 2 trial of plerixafor, tacrolimus in acute respiratory distress syndrome (ARDS), sponsored by MedRegen LLC. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
plerixafortacrolimus
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT06308926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06308926.